BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7621582)

  • 1. Brain-reactive autoantibodies in BB/d rats do not recognize glutamic acid decarboxylase.
    Davenport C; Lovell H; James RF; Todd I
    Clin Exp Immunol; 1995 Jul; 101(1):127-35. PubMed ID: 7621582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antibodies against both isoforms of glutamate decarboxylase in BB/OK rats by western blotting and immuno trapping enzyme activity assay.
    Lühder F; Woltanski KP; Hamann J; Klöting I; Ziegler B; Ziegler M
    Diabetes Res; 1992; 20(4):97-107. PubMed ID: 1345008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus.
    Mackay IR; Bone A; Tuomi T; Elliott R; Mandel T; Karopoulos C; Rowley MJ
    J Autoimmun; 1996 Dec; 9(6):705-11. PubMed ID: 9115572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.
    De Aizpurua HJ; Wilson YM; Harrison LC
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9841-5. PubMed ID: 1409709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
    Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
    Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
    Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
    Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
    Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
    Björk E; Velloso LA; Kämpe O; Karlsson FA
    Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies to glutamate decarboxylase in children with newly detected insulin-dependent diabetes mellitus].
    Trofimenko EV; Zlobina EV; Lebedev NV; Martynova MI; Piliutik VF; Shchegol'kova TS; Zlobina EN; Dedov II
    Probl Endokrinol (Mosk); 1994; 40(2):18-21. PubMed ID: 8197083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical differentiation of monoclonal GAD antibodies recognizing linear or conformational epitope regions.
    Augstein P; Ziegler B; Schlosser M; Flassig S; Strebelow M; Ziegler M
    Pancreas; 1997 Aug; 15(2):139-46. PubMed ID: 9260198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to glutamate decarboxylase detected in diabetes-prone BB/OK rats do not distinguish onset of diabetes.
    Ziegler M; Schlosser M; Hamann J; Vieregge P; Lühder F; Klöting I; Ziegler B
    Exp Clin Endocrinol; 1994; 102(2):98-103. PubMed ID: 8056059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide specificity of high-titer anti-glutamic acid decarboxylase (GAD)65 autoantibodies.
    Rharbaoui F; Granier C; Kellou M; Mani JC; van Endert P; Madec AM; Boitard C; Pau B; Bouanani M
    Immunol Lett; 1998 Jul; 62(3):123-30. PubMed ID: 9698109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of recombinant human glutamic acid decarboxylase (GAD) in myeloma cells and enzyme-linked immunosorbent assay (ELISA) for autoantibodies to GAD.
    Matsuba T; Yano M; Abiru N; Takino H; Akazawa S; Nagataki S; Yasukawa K
    J Biochem; 1997 Jan; 121(1):20-4. PubMed ID: 9058186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.
    Martino GV; Tappaz ML; Braghi S; Dozio N; Canal N; Pozza G; Bottazzo GF; Grimaldi LM; Bosi E
    J Autoimmun; 1991 Dec; 4(6):915-23. PubMed ID: 1812896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes.
    Daw K; Powers AC
    Diabetes; 1995 Feb; 44(2):216-20. PubMed ID: 7532143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
    Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.